Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (10) , 1035-1038
- https://doi.org/10.1016/0277-5379(90)90045-u
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- DNA index, S-phase fraction, histological grade and prognosis in breast cancerBritish Journal of Cancer, 1990
- Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic ChemotherapyJNCI Journal of the National Cancer Institute, 1989
- Measurement of S‐phase fractions in lymphoid tissue comparing fresh versus paraffin‐embedded tissue and 4′,6′ ‐diamidino‐2 phenylindole dihydrochloride versus propidium iodide stainingCytometry, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasisCancer, 1986
- Pathologic findings from the national surgical adjuvant breast project.VIII. Relationship of chemotherapeutic responsiveness to tumor differentiationCancer, 1983